- Home
- MNPR vs RBB Comparison
MNPR vs RBB Comparison
Compare MNPR & RBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNPR | RBB |
|---|---|---|
| Founded | 2014 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 368.9M | 363.0M |
| IPO Year | 2019 | 2017 |
Fundamental Metrics
Financial Performance| Metric | MNPR | RBB |
|---|---|---|
| Price | $58.91 | $22.90 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 2 |
| Target Price | ★ $107.00 | $22.00 |
| AVG Volume (30 Days) | ★ 160.0K | 81.1K |
| Earning Date | 05-08-2026 | 04-20-2026 |
| Dividend Yield | N/A | ★ 2.68% |
| EPS Growth | ★ 54.99 | 24.49 |
| EPS | N/A | ★ 0.66 |
| Revenue | N/A | ★ $5,167,000.00 |
| Revenue This Year | N/A | $20.50 |
| Revenue Next Year | N/A | $6.90 |
| P/E Ratio | ★ N/A | $35.27 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $28.40 | $15.95 |
| 52 Week High | $105.00 | $24.73 |
Technical Indicators
Market Signals| Indicator | MNPR | RBB |
|---|---|---|
| Relative Strength Index (RSI) | 52.54 | 44.30 |
| Support Level | $50.60 | $20.11 |
| Resistance Level | $61.51 | $24.72 |
| Average True Range (ATR) | 4.38 | 0.58 |
| MACD | 0.47 | -0.20 |
| Stochastic Oscillator | 51.18 | 5.41 |
Price Performance
Historical ComparisonAbout MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About RBB RBB Bancorp
RBB Bancorp operates as a bank holding company. It provides various banking products and services such as checking, savings, money market accounts, and certificates of deposits. Its Specific services include remote deposit, E-banking, mobile banking, commercial and investor real estate loans, business loans and lines of credit, Small Business Administration (SBA) 7A and 504 loans, mortgage loans, trade finance, and a full range of depository accounts. It generates its revenue from interest received on loans and leases and, to a lesser extent, from interest received on investment securities and derives income from noninterest sources, such as fees received in connection with various lending and deposit services, loan servicing, gain on sales of loans, and wealth management services.